M003

R-(−)-Deprenyl -hydrochlorid

powder, ≥98% (HPLC)

• Synonym(e): (R)-(−)-N,α-Dimethyl-N-(2-propinyl)-phenethylamin -hydrochlorid, (R)-(−)-N-α-Dimethyl-N-2-propinyl-benzolethanamin -hydrochlorid, Selegilin -hydrochlorid
• Empirische Formel (Hill-System): C₁₃H₁₇N · HCl
• CAS-Nummer: 14611-52-0
• Molekulargewicht: 223.74
• MDL-Nummer: MFCD00069299
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 24278577
• NACRES: NA.77

Eigenschaften

• Assay: ≥98% (HPLC)
• Form: powder
• Optische Aktivität: [α]25/D −10.8°, c = 6.48 in H₂O(lit.)
• Farbe: white
• mp (Schmelzpunkt): 141-142 °C
• Löslichkeit: H₂O: >10 mg/mL
• Ersteller: Sanofi Aventis
• SMILES String: Cl[H].C[C@H](Cc1ccccc1)N(C)CC#C
• InChI: 1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1
• InChIKey: IYETZZCWLLUHIJ-UTONKHPSSA-N
• Angaben zum Gen: human ... MAOB(4129)

Beschreibung

Biochem./physiol. Wirkung

Selektiver MAO-B Hemmer; Antiparkinsonmittel.

Leistungsmerkmale und Vorteile

This compound is featured on the Dopamine and Norepinephrine Metabolism and Histamine Synthesis and Metabolism pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H302,H336
• P-Sätze: P301 + P312 + P330
• Gefahreneinstufungen: Acute Tox. 4 Oral - STOT SE 3
• Zielorgane: Central nervous system
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 1
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type N95 (US)